NCT07165028 A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) Status RECRUITING Phase PHASE3
NCT07099742 Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM) Status NOT_YET_RECRUITING Phase N/A
NCT07096908 Tirzepatide Use in People With Obesity and Type 1 Diabetes Status RECRUITING Phase PHASE4
NCT07096063 Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk Status COMPLETED Phase N/A
NCT07095517 Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors Status RECRUITING Phase PHASE1
NCT07091734 Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024 Status RECRUITING Phase PHASE2
NCT07088718 Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data Status COMPLETED Phase N/A
NCT07078838 Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07000955 Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06980623 Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06976853 Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease Status RECRUITING Phase PHASE2
NCT06965413 A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06962280 A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06939088 Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder Status RECRUITING Phase PHASE2
NCT06937099 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight Status RECRUITING Phase PHASE3